Skip to main content
. 2022 Jun 13;13:3403. doi: 10.1038/s41467-022-31088-8

Table 1.

Identification of rare, pathogenic ASPH variants in four families with EHI/MHS.

Variant name V54A K88T D149H K202R
Chr 8 8 8 8
Position (GRCh 37) 62596603 62580807 62577998 62577838
Ref A T C T
Allele G G G C
Consequence missense_variant missense_variant missense_variant missense_variant
SYMBOL ASPH ASPH ASPH ASPH
CDS_position 161 263 445 605
Exon 2 4 5 5
Protein_position 54 88 149 202
Amino_acids V/A K/T D/H K/R
Codons gTt/gCt aAa/aCa Gac/Cac aAg/aGg
Existing_variation rs779765042 rs1236122813 rs145678786, COSV100727527
gnomAD_AF 0.0001076 0.00001924 0.0008436
SIFT deleterious(0.01) tolerated(0.07) deleterious(0.04) deleterious_low_confidence(0)
PolyPhen probably_damaging(0.996) probably_damaging(0.976) possibly_damaging(0.824) benign(0.084)
CADD_PHRED 27.9 22.5 16.1 9.921
Clinical diagnosis MHS/EHI EHS MHS/EHI EHS
Contracture test CHCT IVCT CHCT IVCT
Caffeine 0.4*(proband), 0.8*(sister) 0 g 0.6* 0 g
Halothane 1.4**(proband), 1.0**(sister) 0.05 g 4.0** 0.1 g

The threshold responses for a positive diagnosis in CHCT were *caffeine >0.3 and/or **halothane >0.7. The threshold for a positive diagnosis in IVCT were 0.2 g force produced at 2 mM caffeine and/or at 2%.